Skip to main navigation Skip to search Skip to main content

Selective CYP11B1 inhibtors as a novel treatment option for endogenous cortisol excess

  • Lavery, Gareth (Co-Investigator)
  • Arlt, Wiebke (Principal Investigator)

Project Details

Short titleSelective CYP11B1 inhibtors as a novel treatment option for endogenous cortisol excess
StatusFinished
Effective start/end date4/01/18 → 3/09/22

Funding

  • Medical Research Council

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
View full fingerprint

  • Urine steroid metabolomics as a diagnostic tool in primary aldosteronism

    Prete, A., Lang, K., Pavlov, D., Rhayem, Y., Sitch, A. J., Franke, A. S., Gilligan, L. C., Shackleton, C. H. L., Hahner, S., Quinkler, M., Dekkers, T., Deinum, J., Reincke, M., Beuschlein, F., Biehl, M. & Arlt, W., 1 Mar 2024, In: The Journal of Steroid Biochemistry and Molecular Biology. 237, 106445.

    Research output: Contribution to journal › Article › peer-review

    Open Access
    File
    179 Downloads (Pure)